blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3687511

EP3687511 - EDIBLE CANNABINOID COMPOSITIONS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  28.10.2022
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  03.07.2020
FormerThe international publication has been made
Status updated on  06.04.2019
Most recent event   Tooltip28.10.2022Withdrawal of applicationpublished on 30.11.2022  [2022/48]
Applicant(s)For all designated states
Canopy Growth Corporation
1 Hershey Drive
Smiths Falls, Ontario K7A 0A8 / CA
[2020/32]
Inventor(s)01 / LEVY, Kurt
382 Silver Creek Rd
Idaho Springs Colorado 80452 / US
 [2020/32]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2020/32]
Application number, filing date18861587.627.09.2018
[2020/32]
WO2018US53196
Priority number, dateUS201762564647P28.09.2017         Original published format: US 201762564647 P
[2020/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019067769
Date:04.04.2019
Language:EN
[2019/14]
Type: A1 Application with search report 
No.:EP3687511
Date:05.08.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 04.04.2019 takes the place of the publication of the European patent application.
[2020/32]
Search report(s)International search report - published on:US04.04.2019
(Supplementary) European search report - dispatched on:EP25.10.2021
ClassificationIPC:A61K31/01, A61K31/122, A61K31/352, A23L29/30, A23L33/10, A23L33/105, A23P10/30, A23P20/10
[2021/47]
CPC:
A23L33/105 (EP,US); A23L29/015 (US); A23L29/035 (US);
A23L29/30 (EP,US); A23L33/10 (EP,US); A23P10/30 (EP,US);
A23P20/105 (EP,US); A23V2002/00 (US); A23V2200/15 (US);
A23V2250/032 (US); A23V2250/15 (US); A23V2250/606 (US);
A23V2250/628 (US); A23V2250/708 (US); A23V2250/712 (US) (-)
Former IPC [2020/32]A61K31/01, A61K31/122, A61K31/352
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/32]
TitleGerman:ESSBARE CANNABINOID-ZUSAMMENSETZUNGEN[2020/32]
English:EDIBLE CANNABINOID COMPOSITIONS[2020/32]
French:COMPOSITIONS DE CANNABINOÏDES COMESTIBLES[2020/32]
Entry into regional phase10.02.2020National basic fee paid 
10.02.2020Search fee paid 
10.02.2020Designation fee(s) paid 
10.02.2020Examination fee paid 
Examination procedure10.02.2020Examination requested  [2020/32]
20.05.2022Amendment by applicant (claims and/or description)
20.10.2022Application withdrawn by applicant  [2022/48]
Fees paidRenewal fee
14.09.2020Renewal fee patent year 03
13.09.2021Renewal fee patent year 04
15.09.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US6290985  (REAM RONALD L [US], et al) [A] 1-15 * column 24, line 35 - line 49 *;
 [Y]WO2014159688  (SC LAB INC [US]) [Y] 2,3,11 * page 3, line 1 - line 5 * * page 6, line 1 - page 7, line 17 * * page 35, line 31 - page 36, line 11; claims 25,29,30,31,32,33,34 * * page 11, line 24 - page 13, line 13 *;
 [Y]US2016081976  (BROMLEY PHILIP J [US]) [Y] 1-15 * paragraph [0009] * * paragraph [0040] * * paragraph [0493] - paragraph [0497]; table 119 *;
 [Y]US2016250270  (WENDSCHUH MICHAEL VICTOR [US], et al) [Y] 2,3,11 * paragraph [0011] - paragraph [0014] * * paragraph [0018] - paragraph [0021] * * paragraph [0371] - paragraph [0383]; claims 1,5,6,7,8,9,10,15-30 *;
 [Y]WO2017059859  (MEDCAN PHARMA AS [DK]) [Y] 1-15 * page 3, line 6 - page 4, line 10 * * page 8, line 17 - page 9, line 9 * * page 13, line 5 - line 10 * * page 16, line 20 - line 22 * * page 26, line 4 - line 15 * * page 30, line 22 - line 24 * * page 34, line 5 - page 35, line 13; figure 2; examples 4,5; tables 2A, 2B, 2C, 2D, 2E *;
 [Y]WO2017161387  (REID CHRISTOPHER BRIAN [US]) [Y] 1-15 * page 55, line last - page 56, line 4; example 8 * * page 62, line 33 - line 35 *;
 [A]  - anonymous, "CBD Tabs", GNPD, MINTEL, (20160429), Database accession no. 3970215, URL: https://www.gnpd.com/sinatra/recordpage/3970215/, XP055848470 [A] 1-15 * abstract *
International search[Y]US2014100269  (GOSKONDA VENKAT R [US], et al) [Y] 7-9, 11-13, 19 * ; abstract; paragraphs [0021], [0026], [0050]-[0053], [0068], [0075] *;
 [Y]US2015064250  (GHEBRE-SELLASSIE ISAAC [US], et al) [Y] 1-21 * ; abstract; paragraphs [0048], [0053], [0055] *;
 [Y]US2016029658  (SEGAWA HIROSHI [JP], et al) [Y] 10 * ; paragraph [0067] *;
 [Y]US2016081976  (BROMLEY PHILIP J [US]) [Y] 21* ; abstract; paragraphs [0011], [0014] *;
 [Y]US2016256395  (DE VRIES JAN ALBERT [NL], et al) [Y] 1-21 * ; abstract; paragraphs [0026], [0057], [0074], [0077] *;
 [Y]US2017266153  (LEVY KURT ARON [US], et al) [Y] 2-5, 17 * , [0063] *
by applicantWO2014159688
 US2015126595
 US2015297556
 US2016081976
 US2016250270
 WO2017059859
 WO2017161387
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.